Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124890842 | 12489084 | 2 | F | 20160610 | 20160707 | 20160622 | 20160708 | EXP | IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-39366IT | BOEHRINGER INGELHEIM | 89.06 | YR | F | Y | 0.00000 | 20160708 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124890842 | 12489084 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 220 MG | N | 22512 | 110 | MG | CAPSULE, HARD | BID | |||||
| 124890842 | 12489084 | 2 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 20 MG | 0 | 20 | MG | GASTRO-RESISTANT COATED TABLET | QD | ||||||
| 124890842 | 12489084 | 3 | C | TRINIPLAS | NITROGLYCERIN | 1 | Transdermal | 10 MG | 0 | 10 | MG | QD | |||||||
| 124890842 | 12489084 | 4 | C | ZYLORIC | ALLOPURINOL | 1 | Oral | STRENGTH: 300MG | 0 | TABLET | |||||||||
| 124890842 | 12489084 | 5 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 124890842 | 12489084 | 6 | C | MIRAPEXIN | PRAMIPEXOLE | 1 | Oral | 0 | |||||||||||
| 124890842 | 12489084 | 7 | C | QUENTIAX | QUETIAPINE FUMARATE | 1 | Oral | STRENGTH: 25MG | 0 | COATED TABLET | |||||||||
| 124890842 | 12489084 | 8 | C | MEDROL | METHYLPREDNISOLONE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124890842 | 12489084 | 1 | Product used for unknown indication |
| 124890842 | 12489084 | 2 | Product used for unknown indication |
| 124890842 | 12489084 | 3 | Product used for unknown indication |
| 124890842 | 12489084 | 4 | Product used for unknown indication |
| 124890842 | 12489084 | 5 | Product used for unknown indication |
| 124890842 | 12489084 | 6 | Product used for unknown indication |
| 124890842 | 12489084 | 7 | Product used for unknown indication |
| 124890842 | 12489084 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124890842 | 12489084 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124890842 | 12489084 | Mouth haemorrhage | |
| 124890842 | 12489084 | Rectal haemorrhage | |
| 124890842 | 12489084 | Sopor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |